Sign in

Alzheimer disease trials, also abroad

822 open Alzheimer disease trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States361
China134
France85
Italy60
Canada58
All other countries

The same trial often runs in several countries

A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) has 2 sites in Switzerland and runs in 14 countries. If a site near you is full, another one may still take people.

See A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) in all 14 countries
Alzheimer disease trials in Switzerland – Frontlight Research